Sign In
Buy LLY
$1,116.11
-5.06 (-0.451%)
At Close: Aug 04, 2026
3 Monster Stocks to Hold for the Next 10 Years
06:05am, Tuesday, 23'rd Jun 2026
These players sell market-leading products and are tackling growth industries. Holding for several years, rather than a short period, allows investors to fully benefit from each company's story.
Why This Mid-Cap Biotech Could Be the Dark-Horse Threat to Eli Lilly and Novo Nordisk
08:15pm, Monday, 22'nd Jun 2026
Viking Therapeutics has a weight-loss program that looks to be competitive with medicines already on the market. It's unclear how its candidate compares to competing programs that are still in clinica
Eli Lilly vs Pfizer: One Owns the Obesity Market Today, The Other Paid to Compete Tomorrow
04:02pm, Monday, 22'nd Jun 2026
Eli Lilly (NYSE: LLY | LLY Price Prediction) and Pfizer (NYSE: PFE) just delivered Q1 2026 results that read like two different chapters of the same drug industry.
Lilly declares third-quarter 2026 dividend
12:00pm, Monday, 22'nd Jun 2026
Lilly declares third-quarter 2026 dividend PR Newswire INDIANAPOLIS, June 22, 2026
Lilly declares third-quarter 2026 dividend
11:00am, Monday, 22'nd Jun 2026
INDIANAPOLIS, June 22, 2026 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the third quarter of 2026 of $1.73 per share on outstanding common s
13 Stocks Are Members of the $1 Trillion Club. Here's the Best Pick to Buy Right Now.
03:52am, Monday, 22'nd Jun 2026
Want to really go big? One megacap stock offers an especially attractive risk-reward proposition.
Lilly's 7 Acquisitions in 3 Months: Which Will Be the Biggest Game-Changer for the Pharma Giant?
10:45am, Saturday, 20'th Jun 2026
Eli Lilly has been buying up many small biotechs recently as it navigates its next steps. The latest deals could open up opportunities for new therapy programs for years to come.
3 Penny Stocks Under $5 Backed by Real Revenue Growth
09:20am, Saturday, 20'th Jun 2026
Investing in penny stocks requires significant conviction. Many of the companies in this group are purely “story stocks.
3 Reasons to Buy Eli Lilly Stock
03:00am, Saturday, 20'th Jun 2026
Eli Lilly still has a large addressable market in the anti-obesity space. The company boasts a deep pipeline of assets within and outside of its core therapeutic areas.
Vertex Has a Head Start in Non-Opioid Pain. Eli Lilly Just Spent Billions to Catch Up.
02:00am, Saturday, 20'th Jun 2026
Vertex Pharmaceuticals and Eli Lilly are both going after the non-opioid pain management market. Vertex Pharmaceuticals has a lead, but both drugmakers could be successful in this niche.
Prediction: Eli Lilly Will Trade at $1,200 on This Date
03:15pm, Friday, 19'th Jun 2026
Eli Lilly (NYSE:LLY | LLY Price Prediction) just reported a quarter that should have sent bulls into a frenzy.
Novo Nordisk Stock Rally as Owner Unveils $69 Million Obesity Research Push
01:01pm, Friday, 19'th Jun 2026
Novo Nordisk (NVO) shares in Copenhagen rose about 5% on Friday after its majority owner, the Novo Nordisk Foundation, launched CardioMetabolic Bridge, a pan-Eu
Eli Lilly (LLY) Stock Sinks As Market Gains: What You Should Know
06:46pm, Thursday, 18'th Jun 2026
Eli Lilly (LLY) closed at $1 in the latest trading session, marking a -1.19% move from the prior day.
Can Pfizer Take Share From Lilly & Novo Nordisk in the Obesity Space?
11:16am, Thursday, 18'th Jun 2026
PFE is betting on monthly obesity treatments and new oral programs to challenge LLY and NVO in a market projected to hit $120 billion by 2035.
3 Stocks Doing the Heavy Lifting in Healthcare's Rebound
09:31am, Thursday, 18'th Jun 2026
Until recently, it had been a lackluster year for the healthcare sector. From high medical utilization squeezing insurers to structural cost pressures and valuation hangovers, medical stocks stocks ha
